Martínez-Delgado Gustavo, Felix Ricardo
Laboratorio de Genómica de Enfermedades Cardiovasculares, Consejo Nacional de Ciencia y Tecnología (CONACYT)-Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Oncology. 2017;93(1):1-10. doi: 10.1159/000464293. Epub 2017 Mar 30.
Extensive research is currently underway, seeking better diagnostic methods and treatments and a better understanding of the molecular mechanisms involved in cancer, from the role of specific genetic mutations to the intricate biochemical and molecular pathways involved. Because of their role in regulating relevant physiological events such as cell proliferation, migration, and invasion, ion channels have recently been recognized as important elements in cancer initiation and progression. Moreover, it has been reported that pharmacological intervention in ion channel activity might provide protection against diverse types of cancer, and that ion channels could be used as targets to counteract tumor growth, prevent metastasis, and overcome the therapy resistance of tumor cells. In this context, Ca2+ channels have been found to play a role in tumorigenesis and tumor progression. Specifically, L-type Ca2+ channel inhibition may affect cell proliferation, differentiation, and apoptosis. This review aims to provide insights into the potential role of these channels in cancer cell lines, emphasizing their participation in cell proliferation, migration, and autophagy induction, as well as their potential as rational targets for new cancer therapeutics.
目前正在进行广泛的研究,以寻找更好的诊断方法和治疗方法,并更深入地了解癌症所涉及的分子机制,从特定基因突变的作用到复杂的生化和分子途径。由于离子通道在调节细胞增殖、迁移和侵袭等相关生理事件中发挥作用,它们最近被认为是癌症发生和发展的重要因素。此外,据报道,对离子通道活性的药理学干预可能为多种类型的癌症提供保护,并且离子通道可作为对抗肿瘤生长、预防转移和克服肿瘤细胞治疗抗性的靶点。在这种背景下,已发现Ca2+通道在肿瘤发生和肿瘤进展中起作用。具体而言,L型Ca2+通道抑制可能影响细胞增殖、分化和凋亡。本综述旨在深入探讨这些通道在癌细胞系中的潜在作用,强调它们参与细胞增殖、迁移和自噬诱导,以及它们作为新型癌症治疗合理靶点的潜力。